Daunorubicin liposomal Side Effects
Medically reviewed by Drugs.com. Last updated on Oct 10, 2022.
Applies to daunorubicin liposomal: intravenous dispersion.
Common (1% to 10%): Decreased left ventricular ejection fraction
Uncommon (0.1% to 1%): Congestive heart failure, cardiomyopathy
Rare (less than 0.1%): Atrial fibrillation, myocardial infarction
Frequency not reported: Shock[Ref]
Very common (10% or more): Alopecia
Rare (less than 0.1%): Palmar-plantar erythrodysesthesia syndrome[Ref]
Frequency not reported: Transient elevations in serum bilirubin, transient elevations in aspartate aminotransferase (AST), transient elevations in alkaline phosphatase (ALP), hepatitis, hepatic failure[Ref]
Very common (10% or more): Asthenia, fatigue, fever, chills[Ref]
Very common (10% or more): infections
Very common (10% or more): Allergic reaction
More about daunorubicin liposomal
Related treatment guides
1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.